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                                                                        Abstract 
 TITLE³$VWXG\WRDVVHVVWKHHIIHFWLYHQHVVRI% citric acid dressing on 
diabetic foot ulcer among clients admitted in selected wards of Rajiv 
*DQGKL*RYHUQPHQW*HQHUDO+RVSLWDO&KHQQDL´ 
Diabetes mellitus is a common disease all over the world and its 
prevalence and incidence is steadily increasing.However people with diabetes 
continue to suffer from the complications of the disease. Foot ulceration is one 
of the most common formidable complications of diabetes 
Need for the study 
Timely resolution of diabetic foot ulceration is essential if further tissue 
loss and infection are to be avoided. Current guidelines recommend the use of 
pressure relieving devices, appropriate dressings to promote healing and 
prevent infection, and where appropriate, debridement, drainage and 
revascularization. 3% citric acid dressing treatment for diabetic foot ulcer is 
simple and effective approach.  
Objectives  
1. To assess the pre test wound status score of foot ulcer among diabetic client 
2. To assess the effectiveness of 3% citric acid dressing on diabetic foot ulcer 
among experimental group  
3. To compare wound status score among experimental and control group. 
4. To associate the post test wound status score with selected demographical 
and physiological variables among experimental and control group 
Key words ±Diabetic foot ulcer, 3% citric acid dressing, and Wound status 
Research methodology 
Research approach ± quantitative approach, Study design ± experimental 
research design, Study setting- medical, surgical, septic and special wards of 
Rajiv Gandhi Government General Hospital Chennai,Sampling technique±
simpling random sampling technique,Tool- Modified Bates Jensen Wound 
Assessment Tool, Sample size-60. 
Data collection procedure  
 Data collection done after obtained approval from institutional ethics 
committee & getting writtten consent from participants, pre test wound status 
score was asssessed by Modified Bates Jesen Wound Assessment tool,applied  
3% citric acid  soaked gauze dressing on the wound once a day for 14 days and 
post test effectiveness  assessed on 14th day by Modified Bates Jesen Wound 
Assessment tool. 
Data analysis: 
The demographical variables were analyzed by using descriptive 
(mean standared deviation, frequency and percentage) and inferential 
statistics (student paired and student inGHSHQGHQWµW¶ WHVW DQG FKL-
square)  
Study results  
 The findings of the study revealed that in experimental group clients 
were reduced 22.1% of wound score after 3% citric acid dressing. Control 
group clients were reduced 7.9% of score.This shows the effectiveness of 3% 
citric acid dressing.Differences between pretest and posttest score was analysed 
using percentage with 95% CI and mean difference with 95% CI. 
Discussion 
  Effectiveness of 3% citric acid dressing on diabetic foot ulcer proves 
that there is significant differences in wound status score among experimental 
and control group. 
 Conclusion 
Local application of 3% citric acid dressing can be used as a routine 
intervention among clients all categorries of wound. An extensive experimental 
study can be conducted for larger number of samples in tthe health care 
settings. 
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CHAPTER-I 
INTRODUCTION 
³/HDUQLQJ LV QRW DWWDLQHG E\ FKDQFH LW PXVW EH VRXJKW IRU ZLWK DUGRU DQG
attendeGWRZLWKGLOLJHQFH´- Abigail Adams 
Encouraging people to adopt healthy life styles and appropriate coping 
strategies are the key aim in health promotion. Diabetes mellitus, commonly 
referred to as diabetes was first identified as a disease associated with "sweet 
urine," and excessive muscle loss in the ancient world. Since, the elevated 
levels of blood glucose lead to spillage of glucose into the urine, the term is 
used.  
The International Diabetes Federation (IDF) Diabetes Atlas, Sixth 
Edition 2014 provides the latest figures, information and projections on the 
current and future magnitude of the diabetes epidemic. Approximately 387 
million adults have diabetes; by 2035 this will rise to 592 million. The 
proportion of people with type 2 diabetes is increasing in most countries.77% 
of adults with diabetes live in low- and middle-income countries .The greatest 
number of people with diabetes are between 40 and 59 years of age. 179 
million people with diabetes are undiagnosed. Diabetes caused 4.9 million 
deaths in 2014; every seven seconds a person dies from diabetes.                
According to World Health Organization (2009) the total number of 
people with diabetes worldwide is 171 million in 2000 and is projected to rise 
up to 366 million in 2030. International working group on the diabetic foot 
(2005) estimated that each year, around 3.8 million adults die from diabetes 
related causes, i.e. 6 deaths every minute.It is estimated that 250 million people 
worldwide have diabetes representing roughly 6% of the adult population (20-
79 age group).  The number is expected to reach 380 million by 2025, 
representing 7.1% of the adult population.  
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 According to WHO (2009) the top 10 countries suffering from diabetes 
are India, China, USA, Indonesia, Japan, Pakistan, Russia, Brazil, Italy and 
Bangladesh .  Recent studies in China, Canada, USA, and several European 
countries have shown that feasible lifestyle intervention can prevent the onset 
of diabetes in people at high risk.  Overall direct health care cost of diabetes 
ranges from 2.5% to 15% annual health care budget of a country.             
       According to Centers for Disease Control and Prevention (CDC - 
2009) from 1980 to 2000, the number of Americans with diabetes is more than 
double. Currently, it is estimated that almost 21 million people in the US are 
affected by diabetes; by 2030 this figure is expected to exceed 30 million 
              The development of diabetic foot ulcers (DFUs) typically results from 
peripheral neuropathy and/or large vessel disease, but most commonly DFUs 
are caused by peripheral neuropathy complicated by deformity, callus, and 
trauma.Vascular insufficiency,infection,and failure to implement effective 
treatment of DFUs are linked to secondary medical complications, such as 
osteomyelitis and amputation. Approximately 15% of DFUs result in lower-
extremity amputation. More than 85% of lower-extremity amputations in 
clients  with diabetes occur in people who have had an antecedent foot ulcer. 
             According to WHO 2010 studies, 25 % of the clients  develop diabetes 
related complications which are mostly due to poor diabetes control. The 
elevated blood sugar levels that occur with diabetes mellitus damage blood 
vessels causing them to thicken and cause poor blood circulation. These ulcers 
are slow to heal and often become deep and infected. Control of infection and 
healing of ulcers is difficult in diabetics due to compromised immunity, 
vasculopathy and neuropathy. 
           Diabetes Impaired glucose tolerance and impaired fasting glycaemia are 
risk categories for future development of diabetes and cardiovascular disease.In 
some age groups, people with diabetes have a two-fold increase in the risk of 
stroke. Diabetes is the leading cause of renal failure in many populations in both 
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developed and developing countries. Lower limb amputations are at least 10 
times more common in people with diabetes than in non-diabetic individuals in 
developed countries; more than half of all non-traumatic lower limb amputations 
are due to diabetes. Diabetes is one of the leading causes of visual impairment 
and blindness in developed countries. People with diabetes require at least two to 
three times the health-care resources compared to people who do not have 
diabetes, and diabetes care may account for up to 15% of national health care 
budgets.In addition, the risk of tuberculosis is three times higher among people 
with diabetes.  
Diabetic foot is often quiet a dreaded disability, with long stretches of 
hospitalization, and impossible mounting expenses, with ever dangling end 
result of an amputated limb. The phantom limb plays its own cruel part on the 
already demoralized psyche. 
New treatments for diabetic foot ulcer continued to be introduced. 
Recent development includes the use of bone marrow derived stem cells, 
negative pressure dressing, bioengineered skin equivalents and growth factor 
therapy, hyperbaric oxygen treatment, Maggot or larval therapy. Like wise 
various modalities are used to treat the diabetic foot ulcer.  Moist wound 
healing is widely accepted concept. Hydrocolloid dressing, enzymatic 
debridment agents, hydrogel dressings are some examples. Platelet derived 
growth factor and living skin equivalent products are the newest technological 
advancement in diabetic foot ulcer care. Though high tech treatments are 
available today the cost associated with these treatments are very high.   
Citric acid treatment for diabetic foot ulcer is simple and effective 
approach. Citric acid shows promise as it causes a boost in fibroblastic growth 
and neovascularisation in wounds, aiding the formation of healthy granulation 
tissue which leads to faster healing and it is economic and affordable to all the 
population 
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1.1 Need for the study 
The global view, which reveals more than 1 million annual limb 
amputations²one every 30 seconds²is even more troubling, particularly since 
the International Diabetes Federation (IDF)  2014 predicts that current global 
prevalence of diabetes will burgeon from 285 million to reach 435 million by 
2030. In the U.S., the burden of diabetes is expected to double from its current 
prevalence²25.8 million adults and children, or 8.3% of the population²by 
2030.              
 India reveals that 70% of undiagnosed diabetes mellitus, which is higher 
than expected. In this 25% of those with diabetes may develop diabetes ulcer. 
Timely resolution of diabetic foot ulceration is essential if further tissue 
loss and infection are to be avoided. Current guidelines recommend the use of 
pressure relieving devices, appropriate dressings to promote healing and 
prevent infection, and where appropriate, debridement, drainage and 
revascularization  
Citric acid treatment of chronic infected wounds offers excellent results. 
It has been found effective against a variety of bacteria causing wound 
infections. In vitro studies have revealed the efficacy of citric acid against 
bacteria resistant to multiple antibiotics.Citric acid shows promise as it causes a 
boost in fibroblastic growth and neovascularisation in wounds, aiding the 
formation of healthy granulation tissue which leads to faster healing. 
The high cost to treat the diabetic foot ulcers make it imperative to 
employ high tech and modern ways of treating it. But in the case of citric acid, 
it is relatively very low cost and reduces nearly 50 percentage of dressing costs. 
Clinical results with this treatment showed early formation of healthy 
granulation tissue and enhancement of the healing process, also it is simple, 
effective, reliable, non toxic and economic approach to treat the diabetic foot 
ulcers. 
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When investigator was posted   in the septic ward found that majority of 
beds occupied with diabetic wound,foul smelling discharge and auto 
amputation complications effect of diabetus.Though we have high tech 
treatment and facilities,these treatments are very costly and became 
unaffordable by the people of middle class society. So the investigator choosen 
simple,cost effective method of treating clients with diabetic foot ulcer. 
Treatment with citric acid proves that it is simple, affordable and effective 
approach for the diabetic foot ulcers. 
Considering the above facts the researcher decided to implement the 
citric acid dressing which is an effective and low cost measure to treat the 
diabetic foot ulcer. 
1.2. Statement of the Problem 
A study to assess the effectiveness of 3% citric acid  dressing on 
diabetic foot ulcer among clients  admitted in selected wards of Rajiv 
Gandhi Government General Hospital, Chennai. 
1.3. Objectives: 
1. To assess the pre test wound status score of foot ulcer among diabetic client 
2. To assess the effectiveness of 3% citric acid dressing on diabetic foot ulcer   
    among experimental group  
3. To compare the wound status score among experimental and control group. 
4. To associate the post test wound status score with selected demographical  
    and physiological variable among experimental and control group 
1.4. Operational definitions 
Effectiveness-Refers to the change in wound status brought about by citric acid 
dressing and also measured in terms of time taken for healing and cost of 
treatment. 
6 
 
3%Citric acid- Refers to the citric acid crystals (Citric acid anhydrous) 
solution which prepared from dissolving 3 grams of citric acid crystals in 100 
ml of sterile water. 
Diabetic foot ulcer -Refers to the  disruption in continuity of skin below the 
ankle. It refers to partial thickness wound among diabetic clients  admitted in 
Rajiv Gandhi Government General Hospital, Chennai as assessed with Bates 
Jensen Wound Assessment Tool. 
Diabetic patient-Refers to clients  who are diagnosed as type I and II diabetes 
mellitus admitted at Rajiv Gandhi Government General Hospital, Chennai. 
Wound Status-Refers to the condition of the diabetic wound in terms of 
wound size, presence of infection, depth of wound, presence of necrotic tissue, 
type and amount of exudates, wound edges, and granulation tissues, measured 
with Bates Jensen Wound Assessment Tool. 
Application of citric acid dressing-Refers to the process of application of 20 
to 30 ml of citric acid absorbent dressing on diabetic wound once daily.  
1.5 Assumption 
Antibacterial and healing property in citric acid may promote diabetic 
wound healing.  
1.6 Hypothesis 
H1:    There is difference in wound status score among experimental   
before and after 3% citric acid dressing  
H2:    There is association between post test wound status score with    
         selected demographical and physiological  variables. 
 
 
7 
 
1.7 Delimitation 
x The data collection period was 4 weeks 
x Study fidings can be generalized and limited to Rajiv Gandhi 
Government General Hospital, Chennai. 
x Subjects selected   within age group  of 41-80 years with Diabetic 
foot ulcer. 
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CHAPTER II 
REVIEW OF LITERATURE 
Diabetes mellitus is a multisystem disease related to abnormal insulin 
production, impaired insulin utilization or both. Diabetes mellitus is a serious 
health problem throughout the world. Diabetes is the leading cause of heart 
disease, stroke, adult blindness, foot ulcers and non traumatic lower limb 
amputations. 
  The present study aims at bringing about the effectiveness of  3% citric 
acid  dressing on diabetic foot ulcer. 
2.1 Review of Literature 
2.2 Conceptual Frame Work 
2.1 Review of Literature 
The review of literature has been done under the following headings: 
2.1.1 Literature related to diabetes mellitus. 
2.1.2 Literature related to diabetic foot ulcer and its treatments. 
2.1.3 Literature related to application citric acid for wound healing. 
2.1. Literature related to Diabetes mellitus. 
Billow., et.al,(2015) conducted a study to assess the prevalence of 
metabolic syndrome  among patients with type 1 diabetes mellitus(T1DM) and 
to look at prevalence of diabetes complications in T1DM with and without 
metabolic syndrome at a tertiary diabetes centre in Chennai, South 
India.Patients with without metabolic syndrome were older, had longer 
diabetes duration, acanthosis nigricans, and increased serum cholesterol. In the 
unadjusted logistic regression analysis, retinopathy, nephropathy and 
neuropathy were associated with metabolic syndrome. Prevalence of 
metabolic syndrome is high among Asian Indian T1DM patients, and its 
presence is associated with increased risk of diabetic retinopathy and 
nephropathy. 
Bhavana Sosale et.al (2015) conducted a retrospective crosssectional 
study  to determine the prevalence of CV risk factors, micro and macrovascular 
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complications in patients with newly diagnosed young onset diabetes across 
India among seven centers from 2013 to 2015. Patients were evaluated for 
complications of diabetes and CV risk factors such as body mass index (BMI), 
hypertension, dyslipidemia, and smoking. In this study demonstrates that 
SDWLHQW¶V ZLWKyoung onset diabetes have micro and macrovascular 
complications at diagnosis. This  study highlights the importance of screening 
patients with YOD for CV risk factors and  micro,macro vascular 
complications of diabetes at the time of diagnosis. 
Saikat Sen Et.al (2015) performed a systemic review to evaluate the 
trends of prevalence, extent of diabetic problem in India based on available 
literatures over a period of 52 years (1960 to 2011). Pertinent literatures 
providing details of sample size, age group, along with prevalence of any of the 
three outcomes of interest, i.e. diabetes mellitus, impaired fasting glucose, 
impaired glucose tolerance were included. In this report  analysed the changes 
in prevalence of diabetes mellitus and prediabetes in India from 103 potential 
literatures. A secular trend regarding increase in diabetic prevalence was 
observed in India, though in rural areas it is slower than urban areas. Extent of 
lack of awareness and carelessness to undergo screening for diabetes was 
clearly demonstrated in the recent study. As a conclusion multidisciplinary 
approach and situation based policy are needed to combat the pandemic. 
Vladimir Vuksan (2013) was conducted randomized controlled trial  to 
assess the effectiveness of viscous fibre on acute and long term metabolic 
improvement in type 2 diabetes mellitus such as reduction in hemoglobin 
A1c,fasting and postprandial giycemia,insulinemia and cardio vascular risk 
factors.Its is helpful in managing diabetes with positive outcomes on vascular 
complications and reduced cardio vascular disease risk.  
Mani, Yarde, & Edmonds (2011) conducted a cohort study to assess 
prevalence of venous incompetence, impaired calf vein hemodynamic, and loss 
of micro vascular control in the skin over the dorsum of the foot in an effort to 
document whether increased retrograde pressure caused due to venous 
incompetence or loss of sympathetic regulation of the microcirculation is 
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present in the diabetic patient who is at risk of foot disease. As a conclusion 
outstanding contribution of this report is the finding of venous incompetence in 
patients with diabetes results in diabetic foot disease. 
Srivijitkamol, Moungngern & Vannaseang (2011) conducted   a 
retrospective study to determine factor(s) associated with reduced assessment 
of diabetic complication and to determine the prevalence of diabetic 
complications in type 2 diabetes patients at the out-patient department (OPD) 
of Internal Medicine at Siriraj Hospital Mahidol University Thailand . There 
was a high prevalence rate of diabetic complications in patients with type 2 
diabetes. Screening for diabetic complications will help to identify patients at 
high risk of concomitant complications even though some practitioners are not 
initially aware of the importance of the diabetic complication screening. This 
study data may help the physician decide to modify treatment to prevent 
disabilities 
Vishwanathan & Kumpatla (2011) conducted a study to assess the 
pattern and causes of amputations in diabetic patients across various parts of 
India.  A total of 1985 type 2 diabetic subjects were selected from 31 centres 
across India. . The major cause for the occurrence of amputations among the 
patients was found to be infection. Almost 90 % of the patients had infection. 
Patients had different types of amputations: major amputations accounting for 
29.1 % (n=377) and minor amputations in 70.9 % (n=918) of subjects. 
Prevalence of neuropathy (82 %) was high and 35 % had peripheral vascular 
disease ue to diabetic mellitus.The study concluded that, foot infection was 
found to be the major cause of amputation in India. 
2.2. Literature related to diabetic foot ulcer and its treatments  
Amit Kumar C. Jain, Viswanath S (2015) conducted a  retrospective 
study to analyse major amputation occurring in patients with diabetic foot 
complication through the new principle and practice of diabetic foot at St 
-RKQ¶V PHGLFDO FROOHJH %DQJDORUH ,QGLD,QIHFWHG XOFHUV ZHUH WKH PRVW
common cause for major amputation. Most patients who underwent major 
amputation had a score ranging from 16-20. 11.54% of the patients who 
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underwent major amputation had osteomyelitis with type 3C diabetic foot 
osteomyelitis being most common.Majority of the patients who undergo major 
amputation in India has type 1 diabetic foot complication. Most of the patients 
undergoing major amputation belong to the high risk category for major 
amputation.        
        Shyam Kishore, et.al. (2015) conducted a crossectional study was to 
determine the distribution of categories of foot at risk in patients with diabetes, 
attending a tertiary care hospital and factors that affect it. Foot at risk was 
classified according to the task force of foot care interest Group of American 
Diabetes Association. Category of foot at risk was correlated with demographic 
and clinical feature .Fifty-two percent patients had foot at risk-category 1 and 
2. Loss of protective sensation (LOPS) was present in 33% (category 1). 
Peripheral arterial disease (PAD) was present in 19% (category 2). Both LOP 
and PAD was present in 10% patients. 95% had never received foot care advice 
by health professionals, let alone prescriptive footwear or vascular 
consultation. 
           Sukhminder Jit Singh Bajwa, (2015) conducted a cross sectional study 
among patients with diabetic foot lesions presenting for amputation suffer from 
various socio-behavioral, psychological and economic constraints, which have 
an impact on the care providers of those affected as well.In this study included 
171 patients in the age group 29-78 years of either sex who underwent either 
amputation or debridement, followed by amputation. The clinical status was 
observed and duly recorded in the performa meant for the study. The socio-
behavioral aspects related to diabetic foot were recorded by interview method 
form patients and their relatives.  A higher occurrence of diabetic foot 
morbidities was found in males (152) than in females (19) with a mean age of 
52.64 years at the time of presentation in their study. Socio-behavioral factors 
such as low literacy levels, treatment by quacks, inadequate foot care and habit 
of walking barefoot, lack of physician follow-up and association of 
concomitant risk factors such as smoking and alcoholism and co-morbidities 
were important triggers for diabetic foot morbidities and subsequent 
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amputation. These also had psychological impacts on its sufferers. Neuropathy 
was the main culprit accounting for 88.89% cases, while neuropathy accounted 
for 11.11% cases.  
Zubair, Malik & Ahmad (2011) conducted a  prospective study  to 
evaluate the incidence and risk factors for amputation among patients with 
diabetic foot ulcer (DFU) in a multidisciplinary based diabetes and 
endocrinology centre of Jawaharlal Nehru Medical College of Aligarh Muslim 
University, India. Detailed history and physical examination was carried out for 
every subject. Risk factors for amputation were determined by univariate 
analysis with 95 % of CI. The overall amputation rate was 28.4 %. The risk 
factors identified for amputation were presence of PVD, leukocytosis, 
neuropathy, nephropathy, hypertension, dyslipidemia, over use of antibiotics, 
osteomyelitis, bio film production and higher grade of ulcer. 
Shankhadar (2009) conducted a study to evaluate the knowledge about 
foot care,type of footwear used,educational level,associaion of tobacco abuse 
and any associated symptoms of foot disease by a structured questionnaire. 
Clinical evaluation was done by inspection of feet for presence of any external 
deformities, assessment of sensory function (vibration perception threshold, 
VPT), vascular status (foot pulses and ankle brachial ratio) and presence of any 
infection.Average duration of diabetes in the high-risk and low-risk diabetes 
group was 10.85 and 9.83 years, respectively. In the high- and low-risk diabetic 
groups, VPT was 11.26 and 10.21V (P < 0.02). The study shows, poor 
knowledge of foot care and poor footwear practices were important risk factors 
for foot problems in diabetes. 
Bansal & Garg (2008) carried out a clinical trial on patients with 
diabetic foot lesions to determine their clinical characteristics, the spectrum of 
aerobic microbial flora and to assess their comparative in vitro susceptibility to 
the commonly used antibiotics. A total of 157 organisms (143 bacteria and 14 
fungi) were isolated and an average of 1.52 isolates per case was reported. 
Polymicrobial infection was found in 35 % of the patients. In this study, 
Pseudomonas aeruginosa among the gram-negative (22 %) and Staphylococcus 
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aureus among the gram-positive (19 %) were the predominantly isolated 
organisms, while Candida was the most predominantly isolated fungus. 
Neuropathy (76 %) and peripheral vascular disease (57.28 %) was a common 
feature among the patients. Poor glycemic control was found in 67 % of the 
patients. Awareness about lower limb complications of diabetes was very low 
(23 %) among the patients. 
Treatments   for Diabetic Foot Ulcers 
Ihtasham Muhammad.et.al (2014) conducted an experimental study to 
assess the role of papaya dressings in the management of diabetic foot in terms 
of healing of ulcers. In this experimental study patients with diabetic foot 
(n=43) were included.  Initial management included empirical antibiotics, 
surgical debridement or amputation, control of glycemia and then wound care 
with the help of papaya dressings. Dressings were changed after every 48 
hours. The wounds were declared healthy when they were filled with healthy 
granulation tissue and had epithelial growth on their edges.Topical papaya 
dressing provides cost effective and favourable outcome in patients with 
diabetic foot ulcer by decreasing the healing duration, reducing surgical 
interventions.  
   Fuijiwara.et.al (2012) conducted a study to assess the effectiveness of a 
preventative foot care nursing programme for diabetic patients. The researchers 
developed a diabetic foot care programme based on the International Working 
Group on the Diabetic Foot and studied 88 patients who attended foot care 
programme for 2 years, and collected data from April 2005 to March 2009. 
Patients were divided into four groups according to the risk classification, and 
received foot care and evaluated the incidence of foot ulceration or recurrence 
and non-ulcerated foot condition. The programme reduced the severity score of 
tineapedis (P < 0·001) and improved callus grade (P < 0·001). The researchers 
found that nurse-based foot care programme is effective in preventing diabetic 
foot in diabetic patients 
Gottrup&Jorgensen (2011) conducted a study to assess the efficacy of 
Maggot debridement therapy (MDT) for treating wound especially diabetic 
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foot ulcers. Literature and the results demonstrate that Maggot debridement 
therapy is a safe method with few side effects. Maggot debridement therapy is 
as good as or better than conventional often surgical debridement, is more 
selective than surgical debridement, because it decreases time to healing and 
stays of patients in the ward, and may decrease the risk of major amputations. 
Dumville & Deshpande (2011) conducted a randomised controlled trial 
(RCTs) to compare the effects on ulcer healing with hydrogel with alternative 
wound dressings or no dressing in the treatment of foot ulcers in people with 
diabetes. The study included 446 participants and the result shows that 
hydrogel dressings are more effective in healing lower grade diabetic foot 
ulcers than the basic wound contact dressings. 
Nain, Uppal, Bajaj & Garg (2011) conducted a study to compare the 
rate of ulcer healing with the negative pressure dressing technique to 
conventional moist dressings in the treatment of diabetic foot ulcers. The study 
was conducted on 30 patients, which were divided into two groups. One group 
received negative pressure dressing while other group received conventional 
saline moistened gauze dressing. Results were compared for rate of wound 
healing. There was a statistically significant difference in the rate of appearance 
of granulation tissue between the two groups; with granulation tissue appearing 
earlier in the study group. The study group promised a better outcome (80 % 
complete responders) as compared to the control group (60 % complete 
responders). Negative pressure wound therapy has a definitive role in healing 
of diabetic foot ulcers. 
Nather (2010) conducted a prospective study to determine the 
effectiveness of vacuum-assisted closure (VAC) therapy in the healing of 
chronic diabetic foot ulcers. An electronic vacuum pump was used to apply 
controlled negative pressure evenly across the wound surface. Changes in 
wound dimension, presence of wound granulation and infection status of 
diabetic foot ulcers in 11 consecutive patients with diabetes were followed over 
the course of VAC therapy.Healing was achieved in all wounds. The average 
length of treatment with VAC therapy was 23.3 days. Ten wounds showed 
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reduction in wound size. All wounds were satisfactorily granulated and cleared 
of bacterial infection at the end of VAC therapy. VAC therapy also provides a 
sterile, more controlled resting environment to large, exudating wound 
surfaces. Large diabetic foot ulcers were thus made more manageable. 
Abdelatif.M.et.al. (2008) conducted a prospective pilot study on safety 
and efficacy of a new honey ointment on diabetic foot ulcers. The objective 
was to study the effectiveness and safety of pedyphar ointment, a new ointment 
prepared from natural royal jelly and panthenol in an ointment base in the 
treating patients with limb-threatening diabetic foot infections. They found out 
that 96% of the patients responded well, with a complete cure, defined as 
complete closure of the ulcer without signs of underlying bone infection and 
concluded that pedyphar ointment is a promising, safe conservative local 
treatment. 
Tiaka, Papanas & Manolakis (2008) investigated the use of 
Hyperbaricoxygen (HBO) in addition to standard treatment of the diabetic foot 
for more than 20 years. Evidence suggests that Hyperbaricoxygen reduces 
amputation rates and increases the likelihood of healing in infected diabetic 
foot ulcers, in association with improved tissue oxygenation, resulting in better 
quality of life.Nonetheless, Hyperbaricoxygen represents an expensive 
modality, which is only available in few centers.The study shows that, 
Hyperbaricoxygen appears promising, but more experience is needed before its 
broad implementation in the routine care of the diabetic foot. 
Duckworth WC.,et.al.,(2004) conducted  a study to assess wound 
healing  process by several agents such as insulin-like growth factor (IGF) and 
human acidic fibroblast growth factor (rh-aFGF).In vivo studies have shown 
that IGF can stimulate the proliferation and differentiation of endothelial cells 
and fibroblasts and promote granulation tissue regeneration to contribute to 
wound healing.Ever since BuntiQJ¶VGLVFRYHU\RILQVXOLQLQPDQ\EHQHILWV
beyond blood glucose regulation have been documented. Preclinical and 
clinical studies have demonstrated positive effects of insulin on wound healing, 
but no suitable method for routine clinical use of topically applied insulin has 
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been reported. Hence we have decided to study the effect of insulin on healing 
on diabetic foot and to develop an appropriate method for topical application of 
insulin. 
2.3 Literature Related To Application Of Citric Acid For Wound 
Healing. 
Vinod Prabhu et.al (2014) conducted a end pilot study to look for cost 
effective method for dressing wounds to minimize loss of working hours in 
Bharati Vidyapeeth University, Sangli, Maharashtra, India. Three percent citric 
acid solution (CA) was used for dressing on nacute lower limb diabetic ulcers 
with the object of pH modulation of wounds at an early stage and to evaluate 
its effects on wound healing.Appearance of healthy granulation was the end 
point of the study. An unicentric randomized double blinded study with a 
parallel design was used to compare patients treated with 3% CA and Eusol 
solutions, respectively. It is concluded that 3% CA solution forms a good 
alternative for wound dressings that acts by modulating the wound pH to acidic 
levels thereby contributing to wound healing by increased fibroblast 
proliferation and probably increasing local oxygen concentration and reducing 
microbial growth and virulence. 
Thool .V,U, et.al (2014) conducted an experimental study in the 
backdrop managing of MRSA and VISA infections in Orthopaedic patients, 
Sevadal Mahila Mahavidyalaya, Nagpur, India .Citric acid was found to be an 
effective permeabilizer and potentiating agent for VISA/MRSA isolates. All 
the VISA isolates (n=9) were susceptible to citric acid except one. Of the 16 
MRSA isolates tested for potentiating activity of citric acid, 14 isolates showed 
an increase in zone diameter size. Two isolates showed an exceptional 
resistance to citric acid. Citric acid offers a novel prophylactic approach for 
controlling MRSA and VISA infections of wounds from orthopaedic 
patientsThe use of citric acid may prevent the development of infections that 
will minimize antibiotic use, prevent development of resistance as well as 
promote healing. 
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Nagoba B, (2012)  conducted a  prospective open study  to assess for 
simple and effective approach for the treatment of traumatic wounds in non-
diabetic patients.An attempt was made to develop a simple and effective 
treatment modality by using citric acid as the sole antimicrobial agent to 
control bacterial infections of traumatic wounds. Citric acid ointment (3%) was 
applied to traumatic wounds to determine its efficacy in their treatment of 
traumatic wounds. Citric acid ointment was found effective in controlling 
infections. Out of 259 cases, 244 (around 95%) were healed completely in 5-25 
applications of 3% citric acid. As citric acid has antibacterial activity and 
wound-healing property; hence it is the best alternative for the treatment of 
traumatic wounds. Besides these properties, citric acid has no adverse effects 
and it is a good dressing agent. 
Hartalkar Amol1, et.al (2012) reported a case from MIMSR Medical 
Collge, Maharastra, India. A  case of 45 years-old male patient with a large 
non-healing ulcer over right leg and also known case of chronic liver disease 
and was having multiple underlying problems. The ulcer was not responding to 
conventional treatment for more than one month. This non-healing ulcer was 
treated simply by local application of three percent citric acid ointment every 
day for a month, which led to complete healing of the ulcer without any 
complications. 
Wadher et.al (2011)  conducted a clinical trial study  to determine 
efficacy of 3% citric acid on surgical site infections. A total of 70 cases of 
surgical site infections not responding to conventional treatment modalities 
were included in the present study. Three per cent citric acid ointment was 
applied to the wound daily once until it healed completely or showed formation 
of healthy granulation tissue.Application of 3% citric acid to wounds resulted 
in complete healing of postoperative wounds or formation of healthy 
granulation tissue in 6 to 25 applications in 69 cases (98.57%). Citric acid 
treatment was found to be safe and useful in the treatment of surgical site 
infections. Hence, the topical use of citric acid is recommended, especially 
when the treatment of surgical site infections is a matter of great concern.These 
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infections are difficult to control and, if not treated in time, increase further 
morbidity. In the present study, an attempt was made to develop simple and 
effective treatment modality by using citric acid as a sole antimicrobial agent to 
control surgical site infections.   
 Vinayak Vaghav, et.al (2011)  reported a case of non-healing sinus in 
mid tarsl region of foot, which did not respond to conventional antimicrobial 
treatment and local care combined for years, but was treated successfully by 
using three percent citric acid as a sole topical antimicrobial agent. In the 
present study, they used citric acid for the treatment of chronic sinus 
successfully. The sinus, which did not respond to anti-.RFK¶V WUHDWPHQW RU
loads of antibiotics, healed completely in 11 (one application a day) 
applications of citric acid. Hence, we can safely suggest the use of citric acid in 
the treatment of a chronic sinus when other conventional modalities are 
exhausted. 
Gandhi (2010) conducted an experimental study to develop a simple 
and effective treatment modality using citric acid as a sole antimicrobial agent 
to control infections in burns patients not responding to conventional treatment. 
Forty-six cases with 5-60 % superficial to deep burns in a study group and 20 
cases with 10-70 % superficial to deep burns in a control group were 
investigated for culture and susceptibility. Application of citric acid to burn 
wounds resulted in complete healing in 40 (86.95 %) cases in 7-25 applications 
(P value 0.145); however, in a control group conventional antibiotic therapy 
and local wound care resulted in complete healing in nine (45 %) patients only. 
Citric acid treatment was found effective in the control of burns infections as 
compared to conventional therapy. Complete healing in 86.95 % cases as 
compared to 45 % in a control group indicates that citric acid is nontoxic, 
economical and quite effective in the management of burns infections 
Gutyon (2009).,conducted  a comparative study  to assess the efficiency 
of citric acid as a dressing in comparison with silver sulfadiazine gauze 
dressing. In 52 patients treated with citric acid and the 91 percent of wounds 
were rendered sterile within 7 days. In 52 patients treated with silver 
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sulfadiazine, 7 % showed control of infection within 7 days. Healthy 
granulation tissue was observed earlier in patients treated with citric acid (mean 
7.4 versus 13.4 days). In control group only 10 % of wounds healed within 15 
days. It shows citric acid as an ideal dressing in the treatment of wound 
healing. 
 Ormerod& Shah (2008), coducted a clinical trail  at  University of 
Wisconsin School of medicine and public health to identify the low cost 
effectiveness of citric acid based dressing for treating diabetic ulcers. The 
experimental group receives citric acid based gauze dressings on the diabetic 
wound for duration of 1 month. At the end of second week granulation tissues 
appeared at a period of 2 to 4 weeks the ulcers resolved completely. It shows 
citric acid based dressing has excellent track on wound healing. 
Allen (2008) conducted an extensive study to evaluate the efficacy of 
citric acid application in the treatment of wound healing. Literature review was 
carried out form July 2000 to July 2008. The 5 observational studies with 165 
patients and 245 cases in 10 controlled trials where 42patients were treated 
with citric acid. Most of the patients reported 95 % of complete wound healing 
within 3- 8 weeks in observational and 62 % in controlled trails. 
Nagoba et.al. (2008) conducted a study to develop an approach, using 
citric acid as a sole antimicrobial agent, for the treatment of chronic wound 
infections caused by multiresistant Escherichia coli (MAREC). A total of 34 
cases of chronic wound infections yielding MAREC isolates on culture were 
studied. The antibacterial effect of citric acid against MAREC was evaluated in 
vitro by broth dilution method. Three percent citric acid gel was applied to each 
wound once daily until it healed completely. All 34 isolates were inhibited by 
citric acid with minimum inhibitory concentrations in the range of 1500-2000 
microg/ml. Topical application of 3 % citric acid to wounds 7-42 times resulted 
in elimination of MAREC from infected sites and successful healing of wounds 
in all 34 patients. This treatment modality was simple, reliable, non-toxic and 
effective. Hence, the use of citric acid for the cost-effective treatment of wound 
infections caused by MAREC is recommended. 
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Nagoba (2007) conducted a study to prove the effect of Citric acid 
treatment for postoperative wound healing in MIMSR medical college, 
Maharashtra. A 40-year-old female presented with history of swelling at the 
upper and middle of the left leg since 6 months was confirmed as post cancer 
surgery non healing wound not responding to conventional antibiotic therapy 
and local wound care in an operated case of synovial sarcoma of the knee, 
monophasic fibrous type with no lung metastasis. Post surgical non healing 
wound not responding to conventional therapy was treated successfully with 
local application of 3 % citric acid ointment for 25 days. And the researcher 
found that treating post surgical wounds with 3 % citric acid is a useful 
measure in the clinical areas. 
Hess (2005) reported in his study, in tissue repair vitamin C directly 
affects the normal production and maintenance of matrix materials especially 
collagen. Vitamin C also strengthens and promotes the formation of new blood 
vessels. With vitamin C deficiency even superficial wounds fail to heal and the 
walls of the blood vessels become fragile and are easily ruptured. 
Van et.al (2003) conducted a randomized clinical trials on diabetic foot 
ulcer patients and found that a novel formulation of metal ions and citric acid 
reduces reactive oxygen species in vitro which plays an important role in 
wound healing. Reactive oxygen species react with nitric oxide produced by 
macrophages to form preoxynitrate, another strong oxidant with detrimental 
effects on surrounding tissue. This study investigated whether samples of metal 
ions and citric acid are able to reduce levels of reactive oxygen species. 
Samples of materials were tested in assays by checking inhibition of reactive 
oxygen species production by poly morphonuclear neutrophils (PMN), 
antioxidant activity and inhibition of human complement. The result shows that 
the citric acid was found to cause significant reduction of super oxide thus 
promoted wound healing.  
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2.2 Conceptual frame work 
 0RGLILHG2UODQGR¶V7KHRU\RI'HOLEHUDWLYH1XUVLQJ3URFHVV 
              Orlando was one of the earliest nurse theorist and one of the first 
people to develop nursing inductively from the empirical study of   nursing 
SUDFWLFH2UODQGR¶VWKHRU\KDVUDGLFDOO\VKLIWHGWKHQXUVH¶VIRFXVIURPPHGLFDO
diagnosis, to thH QXUVLQJ GLDJQRVLV WKDW LV ILQGLQJ DQG PHHWLQJ WKH FOLHQW¶V
immediate needs. 
               2UODQGR¶V QXUVLQJ SURFHVV LV FRPSRVHG RI WKH IROORZLQJ EDVLF
elements 
1. &OLHQW¶VEHKDYLRXU 
2. Reaction of the nurse 
3. The  Nursing activities  which are designed for  the clients  distress 
Orlando says that nurses should help in relieving the physical and mental 
GLVFRPIRUWDQGVKRXOGQRWDGGWRWKHFOLHQW¶VGLVWUHVV 
In this theory, Nursing process is used by nurses to meet the clients 
needs.Meeting the needs improves the FOLHQWV¶VEHKDYLRXU&OLHQW¶VEHKDYLRXU
can be increased body temperature, rigor, vomoting, body pain, fatigue, dis 
FRPIRUW1XUVH UHDFWV WR WKH FOLHQW¶V EHKDYLRXU DQG DFW DFFRUGLQJO\$IWHU
completion, the nursing action is evaluated for its effectiveness. 
  Patient Behaviour   
Patient need is to improve wound status which is caues by Diabetic 
PHOLWXV7KHFOLHQWZKRFDQQRW UHVROYHDQHHGIHHOVKHOSOHVVDQG WKHSHUVRQ¶V
behaviour reflects this feelings. Patient behaviour can be verbal ( expressed by 
language such as complaints of foot ulcer) or non verbal ( manifestation like 
edema,exudate,discomfort,immobility). 
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Nurse Reaction  
           Nurse perceives the clients behaviour (demographical and physiological 
variable) and feels that the client has some needs to be met validating the same 
by communicating   with the client, the nurse investigator assesses the pre 
assessment level of wound score by Bates Jensens Wound Assessment Scale. 
 Nurse Action  
Nurse activity can be automatic or instinctive, deliberative. 
 In automatic nurse  actions  includes decided on for reasons other than 
WKHSDWLHQW¶VLPPHGLDWHQHHGLQFOXGHJLYLQJPHGLFDWLRQDQGSHUIRUPLQJURXWLQH
patient care for control group. 
Deliberative nurse actions involving exploring the meaning (wound 
status)  and relevance of an action to the patient ( 3% citric acid dressing) and 
actions are evaluated for effectiveness after completion  (post test). 
           In deliberative nurse  actions  involves exploring the meaning 
(verifying) and identifying the nHHG RI WKH FOLHQW7KH QXUVH LQYHVWLJDWRU¶V
activity is in planning and implementing the nursing action for meeting the 
FOLHQW¶V QHHGV RU LPSURYLQJ WKH FOLHQW EHKDYLRXU  LPSURYH ZRXQG KHDOLQJ
Here the nurse action is application of  3% citric acid dressing  for 14 days for 
experimental group and post assessment done on 14th day to find out 
effectiveness of nurse action.If  there is marked reduction in wound score, 
encourge to follow the therapy.  
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CHAPTER III 
METHODOLOGY 
  This chapter deals with the methodology to assess the effectiveness of 
3% citric acid dressing on diabetic foot ulcer among patients admitted in 
selected wards of Rajiv Gandhi Government General Hospital, Chennai. 
Research methodology includes the research approach, Research design, 
Duration of the study, study settings, study population, sample size, sample 
selection criteria, sampling technique, Research variables of the study, setting, 
population, sample, criteria for sample selection, sampling technique, 
Development and description of the tool, scoring procedures,intervention 
protocol,content validity, pilot study, reliability of the tool, procedure for data 
collection and plan for statistical analysis. 
3.1. Research approach  
     The quantitative research approach was used to evaluate the 
effectiveness of 3% citric acid dressing on diabetic foot ulcer among patients 
admitted in selected wards of Rajiv Gandhi Government General Hospital, 
Chennai. 
3.2 Data collection period 
 The study was conducted for the period of four weeks (from16.7.2015 to 
15.8.2015) 
3.3 Study setting 
 The study was conducted in selected wards of Rajiv Gandhi 
Government General Hospital, Chennai Tamilnadu.It is one of the biggest 
hospitals in South East Asia with 3000 beds  and funded & managed by state 
government of TamilnNadu.It has all specialities and super specialities services 
are rendered by the hospital. The hospital  is treating about 10,000 to 12,000 
out patients every day.  
 The Department of General surgery was started in the year 1960 and it 
has been upgraded as a Institute of general surgery on Feb 2, 2014. The current 
bed strengh of the Institute  of General Surgery is 200,which includes General 
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wards,Special,Septic wards & intensive care units.This is one of the largest 
department in a Government Hospital among India.Dr Ragumani MS,is 
Director & Professor of Institute of the General Surgery.There are 7 units in 
this Department and admissions  are done throughout the week, 3-5 diabetic 
wound debridement/day, 3 amputation/week are carried.Those affected with 
diabetic foot ulcers are treated in the surgical wards and special & selected 
wards of  Rajiv Gandhi Government General Hospital, Chennai.In 2015 current 
out patient census was 50,000 in which 1/3 patient was diabetic foot ulcer. 
3.4 Study design 
The research design used in the study is expreimental  design. In 
expreimental  design Pretest ±Post test control group design. 
 Experimental  
group 
O1 X O3 
 
Control group 
O2 --- O4 
Keys: 
O1     Observation on experimental group before intervention 
O 2   Observation on control group before intervention  
  X      Intervention  
  O3    Observation on the experimental group after intervention 
  O4    Observation on the control group intervention  
  ---     Routine management 
3.5   Study population 
The target  population of  the present study is the adults between the age 
group of 41-80 years patients with diabetic foot ulcer admitted at  Rajiv Gandhi 
Government General Hospital, Chennai. 
3.6   Sample size  
  The study sample comprises of 41- 80 years male and female diagnosed 
to have Diabetic foot ulcer admitted in selected wards of Rajiv Gandhi 
Government General Hospital, Chennai.The sample size for the study was 60. 
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Out of which 30 samples who receive 3% citric acid dressing belong to the 
experimental group and 30 samples who do not receive 3% citric acid dressing 
belong to the control group. 
3.7. Criterian for selection of samples 
3.7.1. Inclusion Criteria: 
 Patients who are willing to provide informed consent 
 Patients with type I and type II diabetes mellitus who are admitted with 
diabetic wound/ diabetic foot ulcer 
 Patients who are in the age group of 41-80 years of either sex 
 Patients who are present at the time of data collection period  
 Patients  who can understand and read English or Tamil. 
3.7.2. Exclusion Criteria: 
 Clients who are critically ill 
 Clients who are on treatment with corticosteroids, radiation therapy and 
immunosuppressive drugs. 
 Clients with protein energy malnutrition as diagnosed by physician.  
 Clients with vascular and neurological problem. 
3.8 Sampling technique 
The samples were selected by simple randomized sampling technique 
based on the inclusive criteria. 
3.9 Research variables. 
 Independent Variable -  3% citric acid dressing 
 Dependent variable ±  Client with the diabetic foot ulcer  
3.10 Development and Description of tool  
 After an extensive review of literature and discussion with the experts 
the following tools are prepared to collect data. 
3.10.1 Development of tool  
  Appropriate tool was selected with the help of review of literature. 
Obtained   expert opinion and content validity from Diabetology and nursing    
statistics department and constructed tool. Pre testing of tool was done during 
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pilot study. Direct assessment of clients was performed during the data 
collection.  
3.10.2 Description of the tool  
 Tool Consists Of Two Sections: A& B 
Section A:Demographic&Physiologic Variable Profoma-Demographic& 
Physiologic data was collected from the patients and hospital records which 
include age, gender, and history of smoking, duration of diabetes mellitus, 
history of foot ulcer, fasting blood sugar and hemoglobin levels,medication, 
dietary pattern, exercise. 
Section B: Modified Bates Jensen Wound Assessment Tool (2001)-Bates 
Jensen Wound Assessment Tool is a standardized tool developed in the 
year1995 by Barbara Bates Jensen and revised in 2001. The Bates Jensen 
wound assessment tool contains 13 characteristics which assess the wound 
status.  These characteristics included location and shape of the wound, size in 
centimeters square, depth, appearance of edges, undermining or tunneling, 
necrotic tissue type and amount, exudate type and amount, surrounding skin 
condition, peripheral tissue edema and induration, granulation tissue 
appearance and epithelialization (Bates-Jensen &MuNees, 2001)  
Scoring and interpretation of the Modified Bates Jensen Wound 
Assessment Tool (2001): 
In the BWAT, 13 characteristics of wound status are scored using a 
Likert-type scale; a score of 1 - indicates the healthy wound and 5 - indicates 
the most unhealthy wound attribute for each characteristics.Item sub scores are 
added to obtain a total score. The scores range from 13-65 with the higher 
number demonstrating a worse condition of the wound. 
The Bates Jensen wound assessment scale (2001) has internal 
consistency and reliability obtained for this tool is 0.91 and yielded high 
correlation. 
Administration of the Tool. 
1. Size: a sterile metric scale was used to measure the longest and widest aspect of 
the wound surface. 
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2. Depth: depth is identified by the most appropriate wound description of the 
following and 1 to 5 scores are given respectively 
 Tissues damaged but no break in skin 
 Superficial, abrasion, blister, or shallow crater. 
 Deep crater with or without undermining of adjacent tissue 
 Visualization of the wound is obscured by necrosis 
 Supporting structures include tendon, joint capsule are also involved. 
3. Edges : edges of the wound is identified  and scored by the following guideline: 
 Indistinct- wound outline is unable to clearly distinguish. 
 Attached -  flat or even wound base 
 Not attached - base of the wound is deeper than the edge 
 Rolled under, thickened -soft to firm and flexible to touch 
 Hyperkeratosis - callous like tissue formation around wound and at edges. 
 Fibrotic, scarred -hard to touch 
4. Undermining: undermining refers to the deep tissue damage around the wound 
margin, and it is assessed by inserting cotton tipped applicator at the wound 
edges and scored as per the guideline in the tool. 
5. Necrotic tissue type: necrotic tissue of the wound is identified according to 
colour, consistency and adherence. 
6. Necrotic tissue amount: transparent metric measuring scale with concentric 
circles divided into 4 (25 %) pie shaped quadrants to determine percent of 
wound involved. 
7. Exudates type: whether the exudate is bloody, serosanguineous, serous, 
purulent, foul or foul purulent is assessed.  
8. Exudates amount: a transparent metric measuring scale with concentric circles 
divided into 4 (25 %) pie- shaped quadrants is used to determine the exudates 
amounta and according to the percentage it is determined that the amount of 
exudates is scant, small, moderate, or large. 
9. Skin colour surrounding wound: the colour of the tissues with in 4 cm of 
wound edge is assessed.  
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10. Peripheral tissue edema: the edema of the peripheral tissue is assessed with in 4 
cm of wound edge. Non pitting edema appears as skin that is shiny and taut. 
Pitting edema is identified by firmly pressing a finger down in to the tissues 
and waiting for 5 seconds, on release of pressure, tissues fails to resume 
previous position and indentation appears.A metric scale is used to find how far 
the edema is spread to the surroundings. 
11. Peripheral tissue induration: it is assessed by gently pinching the tissues. 
Induration results in an inability to pinch the tissues. A metric scale is used to 
find how far the induration is spread. 
12. Granulation tissue:  it is identified by visualising the wound. When the tissue is 
bright, beefy red, shiny, and granular with a velvety appearance it is said to be 
healthy. Poor tissue health appears as pale pink or blanched to dull, dusky red 
colour. 
13. Epithelialisation:  a transparent metric measuring scale with concentric circles 
divided into 4 (25 %) pie shaped quadrants to determine percentage of wound 
involved. 
            The scores obtained are interpreted as; increase in the wound status 
score indicates the wound degeneration and poor wound healing. Decrease in 
the wound status score indicates the wound regeneration and tissue healing. 
                        Table 3.1 Score Interpretation 
S.NO SCORE RESULT 
1 50-60 Unhealthy 
2 40-49 Moderate  
3 30-39 Mild 
4 20-29 Good 
5 <19 Healthy 
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3.10.3 Intervention protocol  
Protocol  Experimental group Control group 
x Place 
 
x Dosage 
 
x Duration 
x Frequency 
x Time 
x Adminstrationby 
Surgical,Spetic and special 
wards  
20-30 ml gauze soaked 3 % 
citric acid dressing  
14 days 
Once in a day  
30 Minutes/day 
 investigator  
 
 Surgical ,Spetic and 
special wards 
Routine  ward care 
14 days 
Once in a day  
30 minutes/day 
investigator  
 
 
3.10.4 Content Validity  
 Content validity was determined by experts from Nursing and Medical 
and Statistician .([SHUWVµV VXJJHVWLRQV DUH LQFRUSUDWHG LQ WKH WRRO.After the 
modifications they agreed this tool for assessing effectiveness 3% citric 
acid on diabetic foot ulcer among patients admitted in selected wards of   Rajiv 
Gandhi Government General Hospital, Chennai 
3.11 Ethical considerations 
            The study was conducted after the approval and ethical clearence of the 
Institutional ethics committee, Madras Medical college and  Rajiv Gandhi 
Government General Hospital,Chennai. The investigator was instructed to 
follow the guidelines of the ethical committee.All subjects were carefully 
informed about the purpose of study, ensure confidenciality of the study 
result.The freedom was given to the patient to leave the study at his/ her will 
without any reason, no routine care was altered or withheld.The investigator 
followed the ethical guidelines which were issued by the research committee. 
Informed written consent was received from all the patients.Obtained from 
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each study participant after giving full information about the study.Anonymity 
was assured to each participant and maintained by the researcher.  
3.12. Pilot Study 
Pilot study was conducted in Rajiv Gandhi Government General 
Hospital, Madras Medical College Chennai for a period of five days. Simple 
random sample of 10 diabetic foot ulcer patients were selected, five were 
assigned to experimental group and five assigned to control group randomly. 
Bates Jensen wound assessment scale was used to assess the wound status. 
Assessment was done every day before each dressing. The result revealed that 
there is a significant improvement in the status of wound after the application 
of 3% citric acid dressing. Pilot study participants are not included in the main 
study. 
3.13. Reliability of the tool  
After pilot study reliability of the tool was assessed by using Split 
of method and its correlation coefficient r value was 0.83. This 
correlation coefficient was very high and it was good tool for assessing 
effectiveness 3% citric acid dressing on diabetic foot ulcer among patients 
admitted in selected wards of   Rajiv Gandhi Government General Hospital, 
Chennai.   
3.14. Data Collection Procedure  
 The investigator obtained permission from the Director, Professor and 
Head of the department Institute of General surgery and Institute of 
Diabetology.Rapport was established  after a brief introduction about the 
study.Informed consent was obtained from each study participants after getting 
full information about study.Anonymity was assured to each participants. 
Collected  demographical  & physiological variables from diabetic 
patients and also pretest assessment of wound status done by using  Bates 
Jensen Wound Assessment Tool. Study samples were selected by simple 
random sampling technique and samples were divided  into two groups 
based on lottery method, odd numbers as experimental group and even number 
as control group. 
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Application of 3% citric acid  dressing to experimental group  and 
routine care for control for control group for 14 days  followed by post 
assessment done on 14 th day by  using Bates Jensen Wound Assessment Tool.  
The investigator followed all ethical principles for collecting the data.The 
procedure is recorded and reported. 
3.15. Data entry and analysis 
The data were analyzed using descriptive statistics, inferential 
statistics. 
Descriptive statistics  
  Frequency and percentge to describe demographical & Physiological 
variables of diabetic clients with diabetic foot ulcer. 
Inferential statistics  
 Student paired-µW¶WHVWWRDVVHVVWKHHIIHFWLYHQHVVFLWULFDFLGGUHVVLQJ
on diabetic foot ulcer among experimental and control group. 
 Student independent- µW¶ test  to compare the effectiveness of  3% citric 
acid dressing on diabetic foot ulcer between experimental and control 
group. 
 Chi - square test  associate the effectiveness of  3% citric acid dressing 
with selected demographical & physiological variables. 
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Figure 3.1 
Schematic Representation of Research Methodology 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data analysis   and Interpretation(descriptive and inferential 
statistics) 
            Research approach -Quantitative  research apporoach 
Research design ± Experimental research  design 
Study setting- General surgery,septic diabetology wards of Rajiv 
Gandhi Government General Hospital, Chennai 
Sample size (60)- experimental group  (30), control group (30) 
Allocation of sample by simple random sampling technique  
Application of 3%  
citric acid dressing 
Post test Routine  ward care  
Experimental group Control group 
                                   Findings of the study 
Target population ± diabetic foot ulcer  patients 
Pre assessment 
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CHAPTER IV 
DATA ANALYSIS AND INTERPRETATION 
 This chapter represents the method of analysis and interpretation of the 
data. The study was conducted to assess the effectiveness  of  3% citric acid 
dressing on diabetic foot ulcer. Data was collected from 60 samples, divide into 
control and experimental group for implementation of intervention.The 
findings were tabulated analyzed and interpreted in this chapter. The data was 
analyzed using descriptive and inferential statistics. 
Organization data  
x Section I : Assessment of demographic and physiological variables of 
FOLHQW¶VZLWKGLDEHWLFIRRWXOFHU 
x Section II: Assessment of  pretest  wound status score of diabetic foot 
ulcer among  experimental and control group before intervention.  
x Section III: Assessemnt of effectiveness of 3% citric acid  dressing 
among  group 
x Section IV: Compare the wound status score of diabetic foot ulcer 
among experimental and control group.  
x Section VI: Associate post test wound status score  with selected 
demographical & physiological  variables  
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Section-I Assessment of demographical and physiological 
variables of clients with diabetic foot ulcer 
Table 4.1 Distribution of demographical data 
 
S. 
No 
 
Demographic 
variables 
                  Group  
 
Tot
al 
Chi 
square 
test 
Experiment(n=3
0) 
Control(n=30) 
       f (in%) f (in%) 
 
 
 
 
1 
Age 
41-50 
years 
5 16.7 9 30 14 
F2=3.01 
p=0.39 
 
51-60 
years 
15 50 11 36.7 26 
61-70 
years 
7 23.3 9 30 16 
71-80 
years 
3 10 1 3.3 4 
 
2 Gender 
Male 20 66.7 20 66.7 40 F2=0.00 
p=1.00 
 
Female 10 33.3 10 33.3 20 
 
 
3 
Duration 
of 
History 
of 
smoking 
Non 
smoker 
13 43.3 11 36.7 22  
 
F2=0.45 
p=0.79 
 
1 - 10 
years 
11 36.7 11 36.7 24 
>10 
years 
6 20.0 8 26.6 14 
6LJQLILFDQWDW3 
+LJKO\VLJQLILFDQWDW3 
9HU\KLJKVLJQLILFDQWDW3***  
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Table 4.1 reveals the distribution of age, gender and history of smoking.  
In regarding age,in experimental group 16.7 % of participants were 
between 61-70 years of age,50.% participants were 51-60 years, 23.3% 
participants were 61-70 years and 10% were 71-80 years. Regarding age, 
incontrol group 30 % of participants were between 61-70 years of age, 36.7% 
participants were 51-60 years, 30% participants were 61-70 years and 3.3% 
were 71-80 years. 
  In regarding gender-In the case of gender, in experimental group 66.7 
% were male and 33.3 % were female. In control group 66.7 % were female 
and 33.3 % were female.  
In regarding history of smoking-History of smoking in experimental 
group shows that 43.3 % were non smokers and 36.7 % were smokers for 1- 10 
years and 20 % were smokers for more than 10 years. In control group 36.7 % 
were non smokers and 36.7 % were smokers for 10 years and 26.6 were more 
than 10 years. 
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Table 4. $VVHVVPHQWRI3K\VLRORJLF9DULDEOHVRIFOLHQW¶VZLWK
diabetic foot ulcer 
 
6LJQLILFDQW DW 3     +LJKO\ VLJQLILFDQW DW 3    9HU\ KLJK
VLJQLILFDQWDW3***  
 
S.
no 
 
Physiologic Variables 
Experimental Group Control Group 
Total 
Chi 
Square 
Test f (in %) f (in %) 
 
 
 
1 
 
Duration of 
diabetic 
mellitus 
<1yrs 7 23.3 5 16.7 12 
F2=0.46 
p=0.97 
 
1 ± 3 yrs 7 23.3 7 23.3 14 
4 ± 6 yrs 8 26.7 9 30 17 
7 ± 9 yrs 2 6.7 2 6.7 4 
>10 yrs 6 20 7 23.3 13 
 
 
2 
Duration of 
History of food 
ulcer 
<1month 11 36.7 9 30 20 
F2=2.71 
p=0.44 
 
1 month 4 13.3 7 23.3 11 
2months 5 16.7 8 26.7 13 
>2month 10 33 6 20 16 
 
 
3 
Mean fasting 
blood sugar 
(mg/dl) 
80 ±120 7 23.3 3 10 10  
F2=3.80 
p=0.28 
 
121 -160 11 36.7 8 26.7 19 
161 -200 9 30.0 13 43.3 22 
>200 3 10.0 6 20 9 
 
 
4 
Hemoglobin 
level (gm/dl) 
9.0 -10.0 11 36.6 9 30 20 
F2=0.68 
p=0.7 
10.111.0 9 30.0 8 26.7 17 
11.1-12.0 5 16.7 6 20 11 
>12.0 5 16.7 7 23.3 12 
 
6 Medication 
OHA 15 50 12 40 27 F2=0.60 
p=0.43 
 
Insulin 15 50 18 60 33 
 
 
7 
Exercises 
Regular 10 33.3 10 33.3 20 F2=0.00 
p=1.00 
 
Irregular 20 66.7 20 66.7 40 
8 
Diet pattern 
Regular 17 56.7 12 40 29 F2=1.66 
p=0.19 
 Irregular 13 43.3 18 60 31 
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 In duration of diabetes mellitus among experimental group 23.3% 
were less than one year, 23.3%were 1-3 years,26.7% were 4-6 years,6.7% were 
7-9 years, 20 % were more than years.In control group  16.7%% were less than 
one year, 23.3%were1-3 years,30 % were 4-6 years,6.7% were 7-9 years, 23.3 
% were more than years. 
 In the case of duration of diabetic foot ulcer, among experimental 
group  36.7% participants were less than one month, 13.3% were one 
month,16.7% were two months ,33% were more than  two months.In control  
group  30% participants were less than one month, 23.3% were one 
month,26.7% were two months ,20% were more than  two months.  
Regarding mean fasting blood sugar  in  experimental  23.3%  mean 
blood sugar ranging between 80-120 mg/dl,36.7% were ranging between 121-
160 mg/dl, 30% were ranging between  161-200 mg/dl  and 10%ranging 
between were > 200mg/dl.In control group 10 % were ranging between 80-120 
mg/dl,26.7% were ranging between 121-160 mg/dl, 43.30% were ranging 
between  161-200 mg/dl  and 20%ranging between  were > 200mg/dl. 
In the case of level of hemoglobin among experimental group  36.6%  
were between  9- 10 gm/dl 30% were between 10.1-11 gm/dl, 16.7% 11.1-12 
gm/dl and 16.7 were >12 gm/dl.In  control  group  30%  were between  9- 10 
gm/dl 26.7% were between 10.1-11 gm/dl, 20% 11.1-12 gm/dl and 23.3% were 
>12 gm/dl 
Regarding type of consuming diabetic medication in experimental 
group 50% were on insulin, 50 % were on oral hypoglycemic agent.  In control 
group  60% (18) were on insulin and 40% were on oral hypoglycemic agent. 
Regarding exercise pattern in experimental group  in experimental 
group 33.3% were on regular exercise pattern, and 67.7 % were on irregular 
exercise pattern. In control  group 33.3% were regular exercise pattern, 66.7 % 
(20)were on irrregular exercise pattern 
 
  
 
 
                 
39 
 
Regarding dietary pattern in experimental group 56.7% were regular 
dietary pattern and 43.3% were on irregular pattern, in  control 40% were on 
regular dietary pattern and 60% were irregular dietary pattern. 
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Section II-Assessment pre test wound status score 
ofexperimental and control group 
Table 4.3-Pretest wound status score among experimental group 
control group 
 
 
 
 
VLJQLILFDQWDW3 
KLJKO\VLJQLILFDQWDW3 
YHU\KLJKVLJQLILFDQWDW3***  
Table 4.3 shows the  mean pre test wound status score of clients with 
diabetic foot ulcer, in experimental group 33.33, in control group  33.07. The 
PHDQ GLIIHUHQFH ZDV  DQG WKH FDOFXODWHG µW¶ YDOXH ZDV 7KHUH LV QR
statistically significant(p=0.75) difference  between wound status between 
control an experimental group. 
 
 
 
 
 
 
 
Test Group 
Wound score 
Mean 
difference 
Student 
independent  
t-test 
Mean SD 
Pretest 
Experiment 33.33 3.22 
0.26 
t=0.31 
p=0.75   Control 33.07 3.41 
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 Section-III  Assessment of effectiveness of 3% citric 
dressing  acid on diabetic foot ulcer clients                                      
Table 4.4 Effectiveness of 3% citric acid on diabetic foot ulcer  
           Group Maximum 
Score 
Mean 
wound 
score 
Mean 
difference in 
wound  score  
with 95% 
confidence 
interval 
Percentage  of  
wound score 
with 95% 
confidence 
interval 
Experiment Pretest 60 33.33 13.27 
(11.91 ± 14.63) 
22.1% 
(19.9%-24.4%) Posttest 60 20.07 
Control Pretest 60 33.07 4.77 
(2.71 ± 6.82) 
7.9 % 
(4.5% ±11.3%) Posttest 60 28.30 
 
Table 4.4 shows that on an average, experimental group clients   were 
reduced 22.1% of wound score after 3% citric acid dressing. Control group 
reduced 7.9% of score .This shows the effectiveness of 3% citric acid 
dressing.Differences between pretest and posttest score was analysed using 
percentage with 95% CI and mean difference with 95% CI. 
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Section IV-Compare the post test wound status score of  diabetic 
foot ulcer among experimental and control group.  
Table 4.5 Comparison of  post test wound status score   among 
experiment and control 
Test Group 
Wound score 
Mean 
difference 
Student 
independent t-
test 
Mean SD 
posttest 
Experiment 20.07 3.59 
8.23 
t=6.59 
p=0.001***  Control 28.30 5.82 
VLJQLILFDQWDW3 
KLJKO\VLJQLILFDQWDW3 
YHU\KLJKVLJQLILFDQWDW3***  
  Table 4.5 In the comparision of post test mean wound status score of  
experiment group was 20.07% and in control group was 28.30% respectively. 
Mean difference between post test score of experimental and control group was 
8.23.There is a statisticaly very high   significant difference (p=0.001***) in 
the wound status among experimental and control group  after intervention. 
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Table 4.6 Comparison of pretest and posttest wound score status of 
experiment and control group 
Group  Test  Wound score Mean 
difference 
Student paired t-
test Mean SD 
Experiment pretest 33.33 3.22 13.27 t=19.97 
p=0.001 ***  posttest 20.07 3.59 
Control pretest 33.07 3.41 4.77 t=2.09  
p= 
0.05** 
posttest 
28.30 5.82 
     significant DW 3  KLJKO\ VLJQLILFDQW DW 3  YHU\ KLJK
VLJQLILFDQWDW3 
Table 4.6 shows the comparison of overall pretest and posttest. 
In the comparison of overall pretest and posttest,in experimental group 
pretest and post test scores were 33.33% score and 20.07% respectively and 
difference is 13.27 score. The FDOFXODWHGµW¶ YDOXH ZDV .There is a 
statistically  very high significant difference (p=0.001 *** ) in wound status 
among experimental group before and after application of citric acid   
Considering control group, in pretest and post test scores were 33.07% 
and 28.30 respectively.Difference is 4.77 score. The FDOFXODWHGµW¶ YDOXH ZDV
2.09. There is a statistically significant difference (p=0.05 **) in wound status 
among experimental group before and after routine care.  
 
 
 
 
 
 
 
  
 
 
                 
44 
 
Table 4.7  comparison of pretest and posttest  mean percentage 
of wound status score  among  experimental group 
Diabetic foot 
ulcer 
Maximum 
score 
Wound score % of wound 
score 
Percentage  
Difference  Mean SD 
Pretest 60 33.33 3.22 55.6 23.5% 
Posttest 60 19.27 2.01 32.1 
7DEOH VKRZV WKH SHUFHQWDJH RI FOLHQW¶V ZLWK GLDEHWLF IRRW XOFHU LQ
experimental group before starting the intervention was 55.6% and the final 
score decreased to 32.1% and the difference between pretest and post test was 
23.5%. 
Table 4.8 Percentage  distribution of pretest and post test level of  
wound status score  before and after 3% citric acid  dressing 
(experimental group) 
Score 
Interpretation  
Pretest Posttest Chi square 
test f (in%) f (in%) 
Very good 0 0.0 17 56.7 F2=52.59 
P=0.001*** 
 
 
  
Good 0 0.0 11 36.7 
Mild 25 83.3 2 6.6 
Moderate 5 16.5 0 0.0 
Poor 0 0.0 0 0.0 
Total 30 100.0% 30 100.0% 
VLJQLILFDQWDW3 
 highly VLJQLILFDQWDW3 
YHU\KLJKVLJQLILFDQWDW3***  
Table 4.8 shows that, in pre test percentage distribution of wound  status 
score among experimental group, 83.3% of them had  mild score, 16.5% of 
them had moderate score . In post test percentage distribution of wound  status 
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score among experiment, 56.7%  of them had very good score, 36.7%  of them 
had good score, 6.6% of them are having mild score. The FDOFXODWHG µChi 
square test¶ YDOXHZDV  There is a  statistically  very  high significant 
difference (p=0.001 ***) in wound status among experimental group before and 
after 3% citric acid  dressing. 
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Table 4.9 Pretest & posttest mean  percentage of wound status 
score among control group  
Diabetic foot 
ulcer 
Maximum 
score 
Wound score % of wound 
score 
Percentage 
difference  Mean SD 
Pretest 60 33.07 3.41 55.1 7.9% 
Posttest 60 28.30 5.82 47.2 
   Table 4.9 shows the percentage of clients with diabetic foot ulcer 
in control group before starting the intervention was 55.1% and the final score 
decreased to 47.2% and the difference was 7.9% which shows that there is mild 
changes wound status after routine dressing.                                
Table 4.10  Percentage Distribution of pretest and posttest level of 
wound status score before and after routine care (control group) 
 Pretest Posttest Chi square 
test f (in %) f (in%) 
Very good 0 0.0 2 6.7 F2=13.55 
P=0.01**  
 
Good 0 0.0 6 20 
Mild 26 86.7 20 66.6 
Moderate 4 13.3 2 6.7 
Poor 0 0.0 0 0.0 
Total 30 100 30 100 
VLJQLILFDQWDW3KLJKO\VLJQLILFDQWDW3 
 YHU\KLJKVLJQLILFDQWDW3***  
Table 4.10 shows  in  pretest percentage distribution of wound status 
score among control, 86.7% of them had mild score ,13.3% of them had  
moderate score. 
In post test percentage distribution of wound status score  among 
control,  6.7% of the clients had very good wound score, 20.0% of them had 
good score, 66.6% of them had mild score, 6.7% of them were having 
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moderate score.The FDOFXODWHG µChi square test¶ YDOXHZDV  There is a  
statistically  highly significant difference (p=0.001 ***) in wound status among 
experimental group before and after  routine dressing. 
 
 
 
 
 
 
 
 
                                           
 
  
 
 
                 
 
Section IV-Association between post test wound score status 
score  with demographical,physiological variable  
Table 4.11 Association   between post test wound status score with 
demographic and physiological variables (experimental group) 
S.no 
Demographical  And 
Physiological Variable 
                  Level of wound score 
Total 
Chi 
square 
test 
Below Average 
 
Below Average 
(>13.27) 
f (in %) f (in%) 
 
1 
Age 
41-50 yrs 1 20 4 80 5 F2=10.03 
p=0.01** 
 
51-60 yrs 5 33.3 10 66.7 15 
60-70yrs 6 85.7 1 16.3 7 
71-80 yrs 3 100 0 0 3 
 
2 Gender 
Male 9 45 11 55 20 F2=6.70 
p=0.03* 
 
Female 6 60 4 40 10 
 
3 Duration of 
smoking 
Non smoker 3 23.1 10 76.9 13 F2=5.40 
p=0.02* 
 
1 - 10 years 8 72.7 3 27.3 11 
>10 years 4 66.7 2 33.3 6 
 
 
4 
Duration of 
diabetic 
mellitus 
< 1 yr 4 57.1 3 42.9 7 
F2=8.37 
p=0.06 
1 - 3 yr 1 14.3 6 85.7 7 
4 - 6 yrs 6 75.0 2 25 8 
7 - 9yrs 2 100. 0 0 2 
> 10 yrs 2 33.3 4 66.7 6 
 
 
5 
Duration of 
diabetic foot 
ulcer 
< 1 month 6 54.5 5 45.5 11 
F2=0.29 
p=0.96 
 
1 month 2 50.0 2 50 4 
2 month 2 40.0 3 60 5 
> 2month 5 50.0 5 50 10 
 
6 Mean fasting 
blood sugar 
level 
80 2 28.6 5 71.4 7 
F2=1.82 
p=0.61 
 
81- 120 6 54.5 5 45.5 11 
121- 160 5 55.6 4 44.4 9 
161 -200 2 66.7 1 33.3 3 
 
7 Haemoglobin 
(Gm/dl 
9.1 - 10.0 5 45.5 6 54.5 11 
F2=3.09 
p=0.38 
10.1 -11.0 3 33.3 6 66.7 9 
11.1 -12.0 3 60. 2 40 5 
> 12.0 4 80 1 20 5 
8 Medication on  OHA 7 46.7 8 53.3 15 F2=3.09 p=0.38 on insulin 8 53.3 7 46.7 15 
 
9 Exercises 
on regular 2 20 8 80 10 F2=5.40 
p=0.02* 
 Irregular 13 60 7 35 20 
10 
Diet pattern 
regular 5 29.4 12 70.6 17 F2=6.65 
p=0.01* Irregular 10 76.9 3 23.1 13 
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Table 4.10 shows the associaton between the demographic variables and 
physiologic variables with post test wound status score of diabetic foot ulcer 
among patients of experimental group. There is association exists between the 
ages, gender, history of smoking and regular exercise pattern and dietary of the 
patients and final wound status score. Younger; non smokers, regular exercise 
and regular diet pattern patients are benefitted more than others.Statistical 
significance was calculated using chi square test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
                 
 
Table 4.12 Association between post test wound status score with 
demographic and physiological variables (control group). 
 
 
S.no Demographical  and 
physiological variable 
Level of wound score 
Total 
Chi 
square 
test 
Below 
Average 
 
Below 
Average 
(>13.27) 
f  (in%) f (in %) 
 
 
1 Age 
41-50 yrs 4 44.4 5 55.6 9    
F2=1.33 
 p=0.71 
 
51-60 yrs 6 54.5 5 45.5 11 
60-70yrs 4 44.4 5 55.6 9 
71-80 yrs 1 100 0 0 1 
 
2 Gender 
Female 10 50 10 50 20 F2=0.00 
p=1.00 
 Male 5 50 5 50 10 
 
 
3 
Duration of 
smoking 
Non 
smoker 3 23.1 10 76.9 13 F2=3.56 
p=0.17 
 
1 - 10 years 8 72.7 3 27.3 11 
>10 years 4 66.7 2 33.3 6 
 
 
4 
Duration of 
diabetic 
mellitus 
< 1 yr 4 57.1 3 42.9 7 
F2=4.88 
p=0.30 
 
1 - 3 yr 1 14.3 6 85.7 7 
4 - 6 yrs 6 75 2 25 8 
7 - 9yrs 2 100 0 0 2 
> 10 yrs 2 33.3 4 66.7 6 
 
5 
Duration of 
diabetic foot 
ulcer 
< 1 month 6 54.5 5 45.5 11 
F2=0.75 
p=0.86 
 
1 month 2 50 2 50 4 
2 month 2 40 3 60 5 
> 2month 5 50 5 50 10 
 
6 
Mean fasting 
blood sugar 
level 
80 2 28.6 5 71.4 7 F2=0.91 
p=0.86 
 
 
81- 120 6 54.5 5 45.5 11 
121- 160 5 55.6 4 44.4 9 
161 -200 2 66.7 1 33.3 3 
 
7 Haemoglobin (G/DL 
9.1 - 10.0 7 77.8 2 22.2 9 
F2=4.56  
p=0.21 
 
10.1 - 11.0 3 37.5 5 62.5 8 
11.1 - 12.0 3 50 3 50 6 
> 12.0 2 28.6 5 71.4 7 
 
8 Medication 
on  OHA 6 50 6 50 12 F2=0.00  
p=1.00 
 on insulin 9 50 9 50 18 
 
9 Exercises 
on regular 4 40 6 60 10 F2=0.60 
p=0.43 
 Irregular 11 55 9 45 20 
 
10 Diet pattern 
 regular  5 41.7 7 58.3 12 F2=0.55 
p=0.45 
 Irregular  10 55.6 8 44.4 18 
VLJQLILFDQW DW 3   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Table 4.11 shows the association between post test wound status score 
with demographic and physiological variable.There is no association exists 
between post test wound status score with demographic physiological variable, 
none of the variables are significant. Statistical significance was calculated 
using chi square test. 
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                                CHAPTER  V 
SUMMARY OF THE RESULTS 
7KHSXUSRVHRIWKHVWXG\ZDV³a study to assess the effectiveness of 3% citric 
acid dressing on diabetic foot ulcer among clients admitted in selected wards of  
5DMLY*DQGKL*RYHUQPHQW*HQHUDO+RVSLWDO&KHQQDL´60 subjects between the 
age group of 41 to 80 years with Diabetic foot ulcer were selected by simpe 
random sampling technique and assigned 30 subjects to experimental group 
and  30 to control group  for each on the basis of inclusion criteria. 3% Citric 
acid dressing was done for the experimental group and routine dressing was 
done for the control group.Demographic & physiologic variables were 
collected and the wound status was assessed for both experimental and control 
group with the help of Bates Jensen Wound Assessment Tool.  The results of 
both groups were compared, interpreted and summarized in this chapter. 
Summary of the demographical variables 
x In demographical variables among the study participants   majority of 
the subjects were in the age group of 51-60 years (43.3%).Regarding 
gender  majorty of subjects were male (66.6%).Regarding history of 
smoking, majority were 1- 10 years smokers (40%) and non smokers 
(40%). 
x In physiological variable regarding history duration of diabetic 
mellitus, majority were 4-6 yrs of  illness (28%).Regarding duration of 
diabetic foot ulcer, majority were < 1 month (33.3%).Majority people 
mean fasting blood glucose level were  161-200mgdl (36.6).Majority 
people hemoglobin level were 9.1- 10 grms.(33.3%).Regarding type of 
 
  
 
 
                 
 
diabetic medication, majority were in insulin (55%).Majority people 
were in irregular exercise pattern (66.6%).Majority people were in 
irregular dietary pattern (51.6%). 
x  Regarding pretest wound status assessment of  experimental and control      
group shows  that there is no significant difference 
( p =0.75) 
x Regarding  pre test percentage distribution  wound status   of 
experimental group shows that,83.3%  clients had  mild  and 16.5 % 
clients had  moderate level of diabetic foot ulcer. 
x Regarding  pre test  percentage  distribution of wound status of control 
group shows that, 86.7% clients had  mild,13.3% clients had  moderate   
level of diabetic foot ulcer . 
x Regarding post test  wound status assessment  of experimental group 
shows that 56.7% clients had healthy wound status. 
x Regarding post test  wound status assessment of control group  shows 
that  most  of the patient  (66.6%)had mild wound healing status. 
x Regarding percentage difference between  pre and post test  mean 
wound status score of  experimental group was 23.5%. 
x Regarding mean percentage difference between  pre and post test mean 
wound status score of  control  group was 7.9%. 
x Comparison of pre and post test assessment wound status score shows 
that  statistically significant of intervention.3 %Citric acid dressing was 
found to be effective in treating the diabetic foot ulcer than routine ward 
care. 
x Regarding effectiveness of 3% citric acid dressing on diabetic ulcer 
shows that 22.1% wound score reduction. 
x Regarding effectiveness of routine ward care on diabetic ulcer shows 
that 7.9 % wound score reduction. 
 
  
 
 
                 
 
x The correlation between the selected demographic and physiologic 
variables with effectiveness of  3% citric acid dressing.shows the 
following results: There was association exists between the age, gender, 
history of smoking and regular exercise pattern and dietary of the clients 
and effectiveness of 3% citric acid dressing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
                 
 
                                                                   CHAPTER VI 
DISCUSSION 
This chapter concentrates on the findings of this study derived from the 
statistical analysis and its pertinence to the objectives set for the study. The 
collected data was collected in two sections. Section A: Demographic and 
Physiological data, section B: Assessment of wound status. 
5.1 Findings related to demographic and physiological variables 
Age. 
  Study results shows that majority of clients were between 51-60 years of 
age, in experimental group 50 % (15), in control group 36.7 % (11). 
A study was conducted by Desai (1997) revealed that age related 
cellular defects are shown by a decrease in the absolute number of cells, the 
number of hair follicles in growth phase, the diminished production of macro 
molecules which results in diminished production of collagen from the dermis 
are the major causes related to delay in wound healing among older adults. 
Gender 
In the case of gender males were majority, in experimental group 66.7% 
(20) were male, in control group 66.7% (20) were male.  
A study conducted by Desiree& Tania(2006) reveals that elderly men 
heal more slowly than elderly women. 
History Of smoking  
 Regarding history of smoking majority of clients were non smoker and 
habit of smoking for about 10 yrs, in experimental group  43.3% (13) were non 
smokers, 36.7 %(11), in control group 36.7 % (11) were non smokers and 36.7 
% (11) were smokers for 10 years.  
Miller & Sandra (2002) explains that smoking delays wound healing 
and the reason for this is smoking causes vasoconstriction and lack of oxygen 
 
  
 
 
                 
 
reaching to the skin cells, decreased collagen synthesis, and delayed growth of 
new blood vessels with in the wound. 
Duration of Diabetic Mellitus 
 Regarding duration of diabetes mellitus, majority of clients were in 
diabetic mellitus for 4-6 years  26.7% (8)  were in experimental group, 30 %( 
9) were in control group.  
A study was conducted by Bennett (2004) reveals a duration of diabetes 
mellitus increases wound status score increasing indicating a slower wound 
healing. 
Duration of Diabetic Foot Ulcer  
In the case of duration of diabetic foot ulcer, majority of clients had 
diabetic foot ulcer  for > 1 month, in experimental group 36.7 % (11), in 
control group 30.0 % (9). 
David, Lynne, Ole & Jesse (2002) conducted a cohort study among > 
3100 individuals with diabetic neuropathic foot ulcer.The result showed that 
longer duration of wound is one of the factors associated with wound healing 
process by 20 week of care. 
Mean Fasting Blood Sugar Level 
Results regarding mean fasting blood sugar shows majority were 
between 121-160 mg/dl, in experimental group 33.3% and in control group 
43.3%. 
A study conducted by Martson (2006) shows that there is a high level of 
positive correlation exists between wound healing and hyperglycemia. The two 
serious consequences of elevated blood sugar levels are a reduction in the 
function of neutrophils as phagocytes and alteration in the deposition of 
collagen by fibroblasts with subsequent reduction in the wound strength. 
 
 
Hemogobin Level 
 
  
 
 
                 
 
Regarding hemoglobin level majority were 9.1-10.mgdl, in experimental 
group 36.6 %( 11), in control group 30 %( 9). 
Sussman & Jensen (2007) stated that Hemoglobin level less than 12 
g/dl in an important risk factor for wound healing 
Medication 
Regarding type of diabetic medication majority clients were on insulin, 
in experimental group 60% (18), in control group 50% (15). 
A study conducted by Koblik, Sieradzki, and Sendur&Biernat (2001) 
shows that subcutaneous insulin injection improves the post ischemic skin 
blood flow in ulcerated feet and they had clinically proven that the time needed 
for healing is highly significant. 
Exercise Pattern  
Regarding exercise pattern majority people were irrregular exercise 
pattern, in experimental 66.7 %( 20) in control 66.7 % (20). 
 A study conducted in saskatoon health region(2011) proves that 
exercise can improve joint mobility, increase blood flow and in decrease 
insulin production and cortisol activity there by wound healing.  
Dietary Pattern  
Regarding dietary pattern majority people were irrregular dietary 
pattern, in experimental 33.3 %( 13) in control 60 % (18) 
 Nancy Collin, Collen Solan (2013) coducted studies that prove that 
comprehensive diet and nutrition management  have been shown  to promote  
optimal glycemic control and facilitate wound  prevention andhealing.  
5.2 Findings based on objectives 
Objective-I: To assess  pretest wound status score of  foot ulcer among  
diabetic clients . 
With regard to effect of citric acid dressing 60 clients with diabetic foot 
ulcer were randomly assigned to experimental and control group. Wound status 
 
  
 
 
                 
 
was assessed with Modified Bates Jensen Wound Assessment Tool both 
experimental and control group.  
The mean difference of initial wound status score of experimental and 
FRQWURO JURXS ZDV  DQG WKH FDOFXODWHG µW¶ YDOXH  ZKLFK LV QRW
significant  at  p=0.75 level of significance. So it is proved that there is no 
significant difference in wound status among the experimental and control 
group before starting the treatment.  
Objective-II: To assess  the effectiveness of 3% citric acid dressing  on 
diabetic foot ulcer among experimental group  
The mean score of clients with diabetic foot ulcer in experimental group 
before starting the intervention was 33.33 and the final score decreased to 
 DQG WKH PHDQ GLIIHUHQFH ZDV 7KH FDOFXODWHG¶ W¶ YDOXH RI
experimental group was 19.97 which shows the effectiveness of 3% citric acid 
dressing on diabetic foot ulcer. 
 In experimental group mean difference in wound score with 95% 
confidence interval was 13.27.  Percentage distribution of wound score with 
95% confidence interval was 22.1% which shows that on an average, 
experimental group reduced 22.1 % of wound score after 3% citric acid 
dressing. 
7KXV³7KHUHLVDVWDWLVWLFDOO\YHU\KLJKVLJQLILFDQWGLIIHUHQFHLQZRXQG
VWDWXVDPRQJH[SHULPHQWDOJURXSEHIRUHDQGDIWHUFLWULFDFLGGUHVVLQJ´LV
accepted. 
Vinod Prabhu et.al (2014) conducted a end pilot study to look for cost 
effective method for dressing wound .Three percent citric acid solution (CA) 
was used for dressing on nacute lower limb diabetic ulcers with the object of 
pH modulation of wounds at an early stage and to evaluate its effects on wound 
healing.Appearance of healthy granulatio was the end point of the study.It is 
concluded that 3% CA solution forms a good alternative for wound dressings 
that acts by modulating the wound pH to acidic levels thereby contributing to 
 
  
 
 
                 
 
wound healing by increased fibroblast proliferation and probably increasing 
local oxygen concentration and reducing microbial growth and virulence. 
Objective III: To compare post test wound status score among experimental 
and control group. 
Comparison of pretest and posttest wound status score 
 In the comparison of overall pretest and posttest, considering 
experiment group pretest and post test mean score were 33.33% and 20.07% 
UHVSHFWLYHO\'LIIHUHQFHLVVFRUHDQGFDOFXODWHGµW¶WHVWYDOXHZKLFK
shows  statistically very high significant  at p=0.001***.  
In control group, in pretest and post test scores were 33.07 and 28.30 
UHVSHFWLYHO\ DQG GLIIHUHQFHZDV  VFRUH 7KH FDOFXODWHG µW¶ WHVW YDOXHZDV
2.09 which  shows statistically significant  at p=0.05*  
In the comparison of post test wound status score of  experiment and 
control group were 20.07 % and 28.30% respectively.Difference between post 
test  wound status score of experimental and control score  is 8.23 and 
FDOFXODWHGµW¶YDOXHZDVZKLFKVKRZVVWDWLVWLFDOO\YHU\KLJK significant  at 
p=0.001*** 
 In comparison of  mean difference before and after citric acid dressing 
of experimental group was 13.27 and the mean difference before and after 
routine wound dressing of control group was only 4.77. This clearly depicts 
that application of citric acid has made an impact in healing of the wound of 
experimental group clients faster than the control group clients 
This proved that there is a significant difference between experimental 
group and control group after treatment. So citric acid dressing is effective in 
treating the diabetic foot ulcer. 
Gutyon (2009)., included 104 cases of superficial burn injury to assess 
the efficiency of citric acid as a dressing in comparison with silver sulfadiazine 
gauze dressing. In 52 clients treated with citric acid and the 91 percent of 
wounds were rendered sterile within 7 days. In 52 clients treated with silver 
 
  
 
 
                 
 
sulfadiazine, 7 % showed control of infection within 7 days. Healthy 
granulation tissue was observed earlier in clients treated with citric acid (mean 
7.4 versus 13.4 days). In control group only 10 % of wounds healed within 15 
days. It shows citric acid as an ideal dressing in the treatment of wound 
healing. 
 7KXV ³7KHUH LV D VLJQLILFDQW GLIIHUHQFH LQ ZRXQG VWDWXV DPRQJ
experimental and FRQWUROJURXSDIWHUDSSOLFDWLRQRIFLWULFDFLG´LVDFFHSWHG 
Objective IV: To find association between selected demographic and 
physiologic variables with final wound status score of control and 
experimental group. 
Association between selected demographic and physiologic variables with 
post test wound status score of experimental group.  
There is association exist between the demographic and physiologic 
variables with post test wound status score of diabetic foot ulcer among clients 
of experimental group. There is association exists between the ages, gender, 
history of smoking, regular exercise pattern and dietary of the clients with final 
wound status score. Younger, non smokers, regular exercise and regular diet 
pattern clients are benefitted more than others.Statistical significance was 
calculated using chi square test.. 
  The association  of  post test wound status score  with  age (F2=10.03 
p=0.01**)VKRZV WKDW VWDWLVWLFDOO\ KLJK VLJQLILFDQW :KLFK SURYHV ³:KHQ WKH
age advances the wound status score also increases which indicates that there is 
DGHOD\LQZRXQGKHDOLQJ´Carrel&Nouy (1997) first time reported in the early 
1920s the delay in wound healing is associated with ageing. It has also been 
reported that complications of wound healing such as wound dehiscence, are 
more common in older people. 
The association  of  post test wound status score  with gender (F2=6.70 
p=0.03*)shows that statistically significant.Sukhminder Jit Singh 
 
  
 
 
                 
 
Bajwa, (2015) A higher occurrence of diabetic foot morbidities was found in 
males than in female. 
  The association of post test wound status score with smoking (F2=5.40 
p=0.02*)VKRZV WKDW VWDWLVWLFDOO\ VLJQLILFDQW:KLFKSURYHV³VPRNLQJGHOD\V WKH
ZRXQGKHDOLQJSURFHVV´$FFRUGLQJWRDVWXG\FRQGXFWHGE\Silverstein (1992) 
the documented effects of the toxic constituents of cigarette smoke--
particularly nicotine, carbon monoxide, and hydrogen cyanide--suggest 
potential mechanisms by which smoking may undermine expeditious wound 
repair. Nicotine is a vasoconstrictor that reduces nutritional blood flow to the 
skin, resulting in tissue ischemia and impaired healing of injured tissue. 
The association of post test wound status score  with exercise pattern  
(F2=5.40 p=0.02*) which shows statistically significant. A study conducted in 
saskatoon health region(2011) proves that exercise can improve joint mobility, 
increase blood flow and in decrease insulin production and cortisol activity 
there by wound healing.   
The association of post test wound status score  with dietary pattern  
(F2=6.65 p=0.01) which shows that  statistically significant.Which 
proves³ZKHQ WKH IDVWLQJ EORRG VXJDU OHYHO
LQFUHDVHG´Apelquvist&Agardh(1992) investigated the association between 
the risk factors and outcome of diabetic foot ulcers and the result shows that 
there is significant association exists with glycemic control by diet with the 
number of days needed for the healing of foot ulcers. 
7KXV ³There is a association between post test wound status score with 
VHOHFWHGGHPRJUDSKLFDODQGSK\VLRORJLFDOYDULDEOHV´LVDFFHSWHG 
                                
 
 
 
  
 
 
                 
 
                                             CHAPTER VII 
CONCLUSION AND RECCOMMENTATION 
Diabetic foot infections are the major cause of morbidity. Inappropriate 
treatment and infections is the common sequel of diabetic foot ulceration that 
leads to delayed wound healing. Diabetic foot ulcers at its later stages highly 
DIIHFWWKHSHUVRQV¶TXDOity of life and image.  
This chapter explains about implications in the field of , nursing 
practice,nursing adminstration,nursing education,nursing research, limitations, 
recommendation for further study. 
The study is to identify the effectiveness  of  3% citric acid dressing  on 
diabetic foot ulcer among diabetic patients. The study design was one group 
pre test and post test with control group. The data was collected for a period of 
4 weeks at Rajiv Gandhi Government General Hospital, Chennai. The study 
was conducted on 60 patients, 30 each were randomly assigned to experimental 
and control group. 3% Citric acid dressing was done for the experimental group 
and routine dressing was done for patients of control group once a day for 14 
days. The wound status was assessed by Bates Jensen Wound Assessment 
Tool. 
7.1. Nursing implications 
7.1.1. Nursing Practice 
The nurse working in the surgical unit should be trained in 
implementing citric acid dressing as complementary therapy to bring out 
positive physical and psychological responses as an adjunctively to other 
pharmacological treatment to promote comfort and well being among the 
diabetic foot ulcer patients. 
7.1.2. Nursing Adminstration 
         Nursing admintration focus towards  the alternative therapy for diabetic 
foot ulcer / foot care should be included in nursing  practice other than routine 
care.Nursing in service programme should be  conducted  for staff nurses  
 
  
 
 
                 
 
about peripheal vascular complication and screening and preventive 
measures.Nursing adminstrater should moniter new changes in  foot care .. 
7.1.3. Nursing Education 
People with diabetic foot ulcer receive various methods of treatment. To 
manage the symptoms effectively many are turning to alternative therapies like 
herbal medicines and various other topical agents. Among these therapies citric 
acid dressing is one of the alternative treatments. In the field of nursing 
education, topical application of citric acid dressing for diabetic wound is 
concerned with holistic care of patients. Thus, it is appropriate to incorporate 
alternative therapies like citric acid dressing into nursing curriculum. 
7.1.4 Nursing Research 
The nursing research need to focus more on the evidence based and 
holistic practice through understanding the various techniques that can bring 
about significant positive and psychological outcomes for patients with diabetic 
foot ulcer. 
The nursing research intended to offer upto date suggestions in 
implementing the alternative treatments like citric acid dressing application as 
one of the nursing intervention for the foot ulcer which is an affordable and 
effective way of treating foot ulcers. 
7.2. Limitations of the study 
1. The study was conducted on less number of subjects. 
2. No comparison was done with specific topical agents used for wound 
dressing. 
7.3. Recommendations for further sudy  
1. Local application of citric acid dressing can be used as a routine 
intervention among patients with diabetic wound in hospitals. 
2. An extensive experimental study can be conducted for larger number of 
samples in the health care settings. 
 
  
 
 
                 
 
3. Further research can be conducted with the help of other wound 
assessment scale. 
4. A study can be conducted to find out effectiveness of citric acid dressing 
in the healing of burns wound. 
5. A comparative study can be conducted with other products used for 
wound dressing.  
 
Citric acid is a product which contains the healing properties and anti 
microbial properties and it is effective in the successful management of foot 
ulcers in an affordable and simple way. 
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               TOOL FOR DATA COLLECTION 
DEMOGRAPHIC AND PHYSIOLOGIC VARIABLE PROFOMA 
PART- A 
1. Sample number    : 
2. Date      : 
3. Age 
a)  41-50                    
b)  51-60 
c)  61-70 
d) 71 -80     
4. Gender 
a) Male 
b) Female     
5. History of smoking     
 a) Non smoker 
 b)1- 10 yrs    
 c)> 1o yrs 
6. Duration of diabetes Mellitus  
a)< 1 yr 
b) 1-3 yr 
c) 4- 6 yrs  
d)7-9yrs 
e) > 10 yrs   
7. History of diabetic foot ulcer     
a)< 1 month  
b) 1 month 
c) 2 month 
 
  
 
 
                 
 
d)> 2month 
8. Fasting blood sugar level  mg/dl   :   
Date:          
FBS:          
a) 80 mg/dl 
b )81- 120 mg/dl 
c)121- 160 mg/dl 
d) 161 -> 200 mg/dl 
8.  Hemoglobin level 
a) 9.1-10 gm/dl   
b)10.1-11gm/dl 
c)11.1-12mg/dl 
d)> 12gm/dl 
9. Medication 
a) on  OHA 
b) on insulin 
10. Exercise : 
a) on regular 
b) irregular 
11. Dietary pattern 
a) on regular dietary pattern 
b) on  irregular dietary pattern 
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WOUND DRESSING PROTOCOL 
 
STEPS RATIONALE 
1.Explain the procedure to the patient and 
get consent 
To get co-operation  
$VVHVVWKHFOLHQW¶VOHYHORIFRPIRUWDQG
check the need for assistance 
 
Removal of dry dressing can be 
painful, client may require pain 
medication. Assistance may be 
needed to open the sterile  pack. 
3. Instruct the client not to touch the 
wound area and sterile supplies. 
Result in contamination of wound 
and supplies  
4. Close room or cubicle curtains Provide privacy and reduces 
airborne microorganisms. 
5. Position the client on supine position or 
lateral position or as comfortably for 
wound dressing  
Provides access to the wound 
6. Apply face mask and protective wear , 
and wash hands thoroughly 
Protects researcher from splashes.  
Reduces transmission of 
pathogens to exposed tissues. 
7. Put on clean gloves and remove the 
dressing and dispose.  
 
Prevents transmission of 
infectious organisms from soiled 
GUHVVLQJWRQXUVH¶VKDnds. 
8. Assess the wound status with the help of 
Bates Jensen Wound Assessment Tool 
Provides the assessment and 
scoring of the wound condition. 
9. Remove gloves and dispose  
10. Keep sterile dressing tray on bedside 
table. 
Sterile dressing remain sterile 
while on or with in sterile surface. 
11. Apply sterile gloves Allows handling sterile supplies 
without contamination. 
 
 
  
 
 
                 
 
12. Open the tray and pour  50 ml of citric 
acid solution with a sterile syringe 
 
13. Clean the wound from least to most 
contaminated area with citric acid solution. 
Assists in debidement and cleans 
wound of debris. 
14. And apply citric acid soaked gauze on 
the wound and cover with gauze pads and 
tape over dressing. In the case of 
circumferential dressing apply gauze roll 
and secure it with adhesive tapes. 
Protects wound from the entrance 
of microorganism. Secures 
dressing in olace. 
15. Remove gloves and dispose. Clean the 
area and replace articles 
Reduces transmission of 
infection. 
16. Assist client to comfortable position Promotes sense of well being to 
the client and enhances comfort. 
17. The procedure is recorded and 
reported. 
 
Recording and reporting is 
essential for ethical and legal 
concerns and also for future 
reference. 
 
(Taylor,2010 & Potter & Perry,2009) 
 
  
 
 
                 
 
INFORMATION TO PARTICIPANTS 
Title of the study   : ³A study to assess the effectiveness of 3% citric acid 
dressing on diabetic foot ulcer among patients   admitted in selected 
wards of rajiv gandhi government general hospital, chennai-03´ 
Name of the Participant : 
Date    : 
Age/sex   :      
Investigator             : Miss. R  KRISHNA VENI 
Name of the institution  : Rajiv Gandhi Government General Hospital,    
                                              Chennai-3 
Enrollment No  : 
You are invited to take part in this study. The information in this 
document is meant to help you decide whether or not to take part. Please feel 
free to ask if you have any queries or concerns. 
You are being asked to co-operate in this study being conducted in Rajiv 
Gandhi Government General Hospital, Chennai-3. 
What is the Purpose of the Research (explain briefly) 
 This research is conducted to evaluate the effectiveness  of 3% citric 
acid on   diabetic foot ulcer among  patients admitted  in Rajiv Gandhi 
Government General Hospital, Chennai-3. We have obtained permission from 
the Institutional Ethics Committee. 
Study Procedures 
 The study will be conducted after obtaining approval from Institutional 
Ethics Committee. 
 
  
 
 
                 
 
 Patients with dibetic foot ulcer  will be explained about the study 
procedures and purpose. 
 Informed consent will be obtained from those who are wiling to 
participate. 
 Those who fulfil the inclusion criteria will be enrolled and randomised 
to either experimental or control group. 
 Pre test assessment  score  of dibetic foot ulcer is been assessed by Bates 
jenson wound assessment  scale .  The experimental group will receive 3 
% citric acid  so  dressing. The control group will undergo ordinary   
saline dressing.  
 Assessment of the final wound status score on the 14 th day of treatment  
by Bates johnson wound assessment  scale. 
Possible Risks to you 
 No risks involved. 
Possible Benefits to you 
 After finishing this study, investigator will provide information that the 
effectiveness of 3%citric acid on diabetic foot ulcer patients  
Possible benefits to other people 
          The result of the research may provide benefits to the patients with 
diabetic foot ulcer and also empathetic care to them by investigator. 
Confidentiality of the information obtained from you 
         You have the right to confidentiality regarding the privacy of your 
personal details. Your privacy in the study will be maintained throughout the 
study in the event of any publication or presentation resulting from the 
research, no personally identifiable information will be shared. The information 
 
  
 
 
                 
 
from this study, if published in scientific journals or presented at scientific 
meetings, will not reveal your identity. 
How will your decision not to participate in the study affect you? 
         Your decisions not to participate in this research study will not affect 
your activity of daily living, medical care or your relationship with investigator 
or the institution. 
Can you decide to stop participating in the study once you start? 
         The participation in this research is purely voluntary and you have the 
right to withdraw from this study at any time during course of the study without 
giving any reasons. 
However, it is advisable that you talk to the research team prior to 
stopping the treatment. 
 
 
Signature of Investigator       Signature of 
Participants 
Date:         Date: 
 
 
 
 
 
 
  
 
 
                 
 
 
 
 
INFORMED CONSENT 
Title of the study   : ³A study to assess the effectiveness of 3% citric acid  
dressing on diabetic foot ulcer among patients   admitted in selected 
wards of rajiv gandhi government general hospital, chennai-03´ 
Investigator                    : R. Krishna veni 
Name of Participant     : 
Age/sex         : 
Date           : 
Name of the institution  : Rajiv Gandhi Government General Hospital,     
                                            Chennai-3 
Documentation of the informed consent: (legal representative can sign if the 
participant is minor or competent). 
x I             have read/it has been read for me, the 
information      in this form. I was free to ask any questions and they 
have been answered. I am over 20 yrs of age and exercising my free 
power of choice, hereby give my consent to be included as a participant 
in the study. 
x I have read and understood this consent form and the information 
provided to me. 
x I have had the consent document explained in detail to me. 
x I have been explained about the nature of my study. 
 
  
 
 
                 
 
x My rights and responsibilities have been explained to me by the 
investigator. 
x I agree to cooperate with the investigator 
x I have not participated in any research study at any time. 
x I am aware of the fact that I can opt out of the study at any time without 
having to give any reason  
x I hereby give permission to the investigators to release the information 
obtained from me as a result of participation in this study to the 
regulatory authorities, government agencies and Institutional ethics 
committee. 
x  I understand that they are publically presented; my identity will be kept 
confidential. 
x I am aware that I have any question during this study; I should contact 
the concerned investigator. 
 
 
Signature of Investigator     Signature of Participants 
Date                   Date 
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